Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP-COLONO FMT Trial
TCTR20260210010Phase 2Recruiting
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Sep 2025
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in irritable bowel syndrome (IBS), sponsored by Gastroenterological Association of Thailand. Started Sep 2025; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on TCTR20260210010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260210010.